Download MendeleyAtomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
Xu, L., Zheng, Q., Li, S., He, M., Wu, Y., Li, Y., Zhu, R., Yu, H., Hong, Q., Jiang, J., Li, Z., Li, S., Zhao, H., Yang, L., Hou, W., Wang, W., Ye, X., Zhang, J., Baker, T.S., Cheng, T., Zhou, Z.H., Yan, X., Xia, N.(2017) Nat Commun 8: 505-505
- PubMed: 28894095
- DOI: https://doi.org/10.1038/s41467-017-00477-9
- Primary Citation of Related Structures:
5XS4, 5XS5, 5XS7 - PubMed Abstract:
Coxsackievirus A6 (CVA6) has recently emerged as a major cause of hand, foot and mouth disease in children worldwide but no vaccine is available against CVA6 infections. Here, we demonstrate the isolation of two forms of stable CVA6 particles-procapsid and A-particle-with excellent biochemical stability and natural antigenicity to serve as vaccine candidates. Despite the presence (in A-particle) or absence (in procapsid) of capsid-RNA interactions, the two CVA6 particles have essentially identical atomic capsid structures resembling the uncoating intermediates of other enteroviruses. Our near-atomic resolution structure of CVA6 A-particle complexed with a neutralizing antibody maps an immune-dominant neutralizing epitope to the surface loops of VP1. The structure-guided cell-based inhibition studies further demonstrate that these loops could serve as excellent targets for designing anti-CVA6 vaccines.Coxsackievirus A6 (CVA6) causes hand, foot and mouth disease in children. Here the authors present the CVA6 procapsid and A-particle cryo-EM structures and identify an immune-dominant neutralizing epitope, which can be exploited for vaccine development.
Organizational Affiliation:
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, PR China.
